Mylan CEO sold $5m worth of stock while EpiPen price drew scrutiny

Heather Bresch sold 100,200 of shares on same day as release of earnings;transaction was ‘part of a 10b5 plan’, which curtails insider trading suspicions
Read more: https://www.theguardian.com/business/2016/aug/27/mylan-ceo-sold-stock-epipen-price-hike-heather-bresch?CMP=edit_2221?source=Snapzu